Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Wilson Tang

Showing results (31-40 of 949) with videos related to

Pageof 95
Sort By:
The American Journal of Cardiology|May 22, 2007
Collaboration among general cardiologists, heart failure specialists, and electrophysiologists: what are the barriers?W H Wilson Tang
Current Heart Failure Reports|November 9, 2010
Ivabradine in heart failure: to SHIFT or not to SHIFTAndres Schuster, W H Wilson Tang
Core Evidence|August 10, 2010
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndromeArash Aghel, W H Wilson Tang
Clinical Science (London, England : 1979)|January 13, 2018
Gut microbiota in cardiovascular disease and heart failureTakeshi Kitai, W H Wilson Tang
Diabetes, Obesity & Metabolism|June 26, 2007
PPARgamma agonists: safety issues in heart failureW H Wilson Tang, Anjli Maroo
European Heart Journal. Acute Cardiovascular Care|May 5, 2021
Carbohydrate antigen 125 in heart failure: congestive kidneys or beyond?Andrew Higgins, W H Wilson Tang
Faculty Reviews|January 14, 2022
Medical management of acute heart failureHayaan Kamran, W H Wilson Tang
Current Treatment Options in Cardiovascular Medicine|February 3, 2016
Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and IvabradineTakeshi Kitai, W H Wilson Tang
Circulation. Heart Failure|May 1, 2023
Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure ProgressionW H Wilson Tang, Weili Zheng
Current Heart Failure Reports|May 25, 2023
Role of Sodium and Sodium Restriction in Heart FailurePieter Martens, W H Wilson Tang
Pageof 95

Showing results (31-40 of 949) with videos related to

Sort By:
Pageof 95
The American Journal of Cardiology|May 22, 2007
Collaboration among general cardiologists, heart failure specialists, and electrophysiologists: what are the barriers?W H Wilson Tang
Current Heart Failure Reports|November 9, 2010
Ivabradine in heart failure: to SHIFT or not to SHIFTAndres Schuster, W H Wilson Tang
Core Evidence|August 10, 2010
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndromeArash Aghel, W H Wilson Tang
Clinical Science (London, England : 1979)|January 13, 2018
Gut microbiota in cardiovascular disease and heart failureTakeshi Kitai, W H Wilson Tang
Diabetes, Obesity & Metabolism|June 26, 2007
PPARgamma agonists: safety issues in heart failureW H Wilson Tang, Anjli Maroo
European Heart Journal. Acute Cardiovascular Care|May 5, 2021
Carbohydrate antigen 125 in heart failure: congestive kidneys or beyond?Andrew Higgins, W H Wilson Tang
Faculty Reviews|January 14, 2022
Medical management of acute heart failureHayaan Kamran, W H Wilson Tang
Current Treatment Options in Cardiovascular Medicine|February 3, 2016
Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and IvabradineTakeshi Kitai, W H Wilson Tang
Circulation. Heart Failure|May 1, 2023
Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure ProgressionW H Wilson Tang, Weili Zheng
Current Heart Failure Reports|May 25, 2023
Role of Sodium and Sodium Restriction in Heart FailurePieter Martens, W H Wilson Tang
Pageof 95